These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pituitary adenylate cyclase-activating polypeptide inhibits the cyclooxygenase pathway of rat cerebral microvessels. Kis B; Gáspár T; Mezei Z; Gecse A; Telegdy G Acta Physiol Scand; 1999 Sep; 167(1):43-7. PubMed ID: 10519976 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658 [TBL] [Abstract][Full Text] [Related]
4. Effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on cyclic AMP accumulation in sheep pituitary cells in vitro. Sawangjaroen K; Sernia C; Curlewis JD J Endocrinol; 1996 Mar; 148(3):545-52. PubMed ID: 8778233 [TBL] [Abstract][Full Text] [Related]
5. A novel hypothalamic peptide, pituitary adenylate cyclase-activating peptide, regulates the function of rat granulosa cells in vitro. Heindel JJ; Sneeden J; Powell CJ; Davis B; Culler MD Biol Reprod; 1996 Mar; 54(3):523-30. PubMed ID: 8835372 [TBL] [Abstract][Full Text] [Related]
6. Pituitary adenylate cyclase-activating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells. Suzuki A; Kotoyori J; Oiso Y; Kozawa O Cell Signal; 1994 Jan; 6(1):11-6. PubMed ID: 7912096 [TBL] [Abstract][Full Text] [Related]
7. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding. Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375 [TBL] [Abstract][Full Text] [Related]
8. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells. Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043 [TBL] [Abstract][Full Text] [Related]
9. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms. Xiao D; Chu MM; Lee EK; Lin HR; Wong AO Neuroendocrinology; 2002 Nov; 76(5):325-38. PubMed ID: 12457043 [TBL] [Abstract][Full Text] [Related]
10. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Akesson L; Ahrén B; Edgren G; Degerman E Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088 [TBL] [Abstract][Full Text] [Related]
11. Evidence for the presence of receptors for pituitary adenylate cyclase-activating polypeptide in the neurohypophysis that are positively coupled to cyclic AMP formation and neurohypophyseal hormone secretion. Lutz-Bucher B; Monnier D; Koch B Neuroendocrinology; 1996 Aug; 64(2):153-61. PubMed ID: 8857610 [TBL] [Abstract][Full Text] [Related]
13. The effects of pituitary adenylate cyclase-activating polypeptide on cerebral arteries and vertebral artery blood flow in anesthetized dogs. Seki Y; Suzuki Y; Baskaya MK; Kano T; Saito K; Takayasu M; Shibuya M; Sugita K Eur J Pharmacol; 1995 Mar; 275(3):259-66. PubMed ID: 7768293 [TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase-activating peptide stimulates cyclic AMP accumulation in UMR 106 osteoblast-like cells. Kovacs CS; Chik CL; Li B; Karpinski E; Ho AK J Endocrinol; 1996 May; 149(2):287-95. PubMed ID: 8708540 [TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells. Hoshino M; Li M; Zheng LQ; Suzuki M; Mochizuki T; Yanaihara N Neurosci Lett; 1993 Sep; 159(1-2):35-8. PubMed ID: 7903438 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide. Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389 [TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase activating polypeptide stimulates rat Leydig cell steroidogenesis through a novel transduction pathway. Rossato M; Nogara A; Gottardello F; Bordon P; Foresta C Endocrinology; 1997 Aug; 138(8):3228-35. PubMed ID: 9231772 [TBL] [Abstract][Full Text] [Related]
18. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex. Zawilska JB; Niewiadomski P; Nowak JZ Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071 [TBL] [Abstract][Full Text] [Related]
19. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles. Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411 [TBL] [Abstract][Full Text] [Related]
20. Pituitary adenylate cyclase-activating polypeptide induces expression of corticosteroid-binding globulin in cultured fetal hepatocytes: synergy with tri-iodothyronine. el Fahime E; Lutz-Bucher B; Felix JM; Koch B Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):643-9. PubMed ID: 8615842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]